Microdissection: A method developed to investigate mechanisms involved in transmissible spongiform encephalopathy pathogenesis

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Barr, Janice B ^a   Somerville, Robert A ^a   Chung, Yuen Li ^b   Fraser, Janet R ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL VACUOLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE TRANSMISSION; GLIOSIS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MICRODISSECTION; MOLECULAR MECHANICS; MOUSE; NEUROANATOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRION DISEASE; REGULATORY MECHANISM; RELIABILITY; SCRAPIE; SCRAPIE AGENT; VIRUS ISOLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATTLE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; PRION DISEASES; PRPSC PROTEINS;

EID: 2442681705     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-4-8     Document Type: Article

References (24)

1. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389:498-501.
2. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H: Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 1994, 343:405-411.
3. Bruce ME, McConnell I, Fraser H, Dickinson AG: The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991, 72 (Pt 3):595-603.
4. Jeffrey M, Fraser JR, Halliday WG, Fowler N, Goodsir CM, Brown DA: Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol 1995, 21:41-49.
5. Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, Sayers AR, Brown DA, Fraser JR: Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 2000, 26:41-54.
6. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH: Scrapie infectivity, fibrils and low molecular weight protein. Nature 1983, 306:476-478.
7. Bolton DC, McKinley MP, Prusiner SB: Identification of a protein that purifies with the scrapie prion. Science 1982, 218:1309-1311.
8. Hope J, Reekie LJ, Hunter N, Multhaup G, Beyreuther K, White H, Scott AC, Stack MJ, Dawson M, Wells GA: Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 1988, 336:390-392.
9. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, et al.: A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985, 40:735-746.
10. Bolton DC, Meyer RK, Prusiner SB: Scrapie PrP 27-30 is a sialoglycoprotein. J Virol 1985, 53:596-606.
11. Stahl N, Baldwin MA, Hecker R, Pan KM, Burlingame AL, Prusiner SB: Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 1992, 31:5043-5053.
12. Endo T, Groth D, Prusiner SB, Kobata A: Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 1989, 28:8380-8388.
13. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB: Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 1986, 83:2310-2314.
14. Kascsak RJ, Rubenstein R, Merz PA, Carp RI, Wisniewski HM, Diringer H: Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol 1985, 66 (Pt 8):1715-1722.
15. Parchi P, Gambetti P: Human prion diseases. Curr Opin Neurol 1995, 8:286-293.
16. Collinge J: New diagnostic tests for prion diseases. N Engl J Med 1996, 335:963-965.
17. Somerville RA: Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J Gen Virol 1999, 80 (Pt 7):1865-1872.
18. DeArmond SJ, Qiu Y, Sanchez H, Spilman PR, Ninchak-Casey A, Alonso D, Daggett V: PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol 1999, 58:1000-1009.
19. Bruce ME, McBride PA, Farquhar CF: Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 1989, 102:1-6.
20. Jeffrey M, Martin S, Barr J, Chong A, Fraser JR: Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol 2001, 124:20-28.
21. Liu WG, Brown DA, Fraser JR: Immunohistochemical comparison of anti-prion protein (PrP) antibodies in the CNS of mice infected with scrapie. J Histochem Cytochem 2003, 51:1065-1071.
22. Castellani RJ, Parchi P, Madoff L, Gambetti P, McKeever P: Biopsy diagnosis of Creutzfeldt-Jakob disease by western blot: a case report. Hum Pathol 1997, 28:623-626.
23. Brown DA, Bruce ME, Fraser JR: Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol 2003, 29:262-272.
24. Sidman L Angevine, JB, Pierce ET: Atlas of the Mouse Brain and Spinal Cord. Harvard University Press, Cambridge Mass.; 1971.